S&P 500 7,443.28 -0.19% NASDAQ 25,508.07 -0.05% DOW 51,839.26 -0.59% R2K 2,945.54 -0.56% VIX 18.55 -1.17% US 10Y 4.60 +1.26% DXY 100.95 +0.20% BITCOIN 65,088.24 +0.61%
Next Bullish Trade
Sign in
SBFM

Sunshine Biopharma, Inc. NCM · SBFM

$1.70 -0.10 (-5.56%)
Pullback · -1.83σ
+ Compare Open in Sniper

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · SBFM

Momentum reads · latest daily bar
Last
$1.70
-0.10 (-5.56%)
Mkt cap
$4M
Healthcare
RSI(14)
27.5
oversold
Stochastic %K
0.0
oversold
MFI(14)
22.7
neutral
ADX(14)
20.5
building

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $0.0B $-0.0B $-0.0B $-0.0B -15.4% -17.3%
2025-12-31 $0.0B $-0.0B $-0.0B $-0.0B -25.0% -19.3%
2025-09-30 $0.0B $-0.0B $-0.0B $-0.0B -9.4% -5.6%
2025-06-30 $0.0B $-0.0B $-0.0B $-0.0B -18.8% -10.6%
2025-03-31 $0.0B $-0.0B $-0.0B $-0.0B -13.3% -14.6%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare SBFM vs peers

Line SBFM up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing SBFM no peers yet — add up to 4 below
Sector peers + LLY + UNH + JNJ + MRK + ABBV + PFE
Popular + AAPL + MSFT + NVDA + AMZN + GOOG + META + TSLA + AVGO
Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP

Add tickers to compare with SBFM

~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.

Earnings replay · last 10 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-05-13 -2.50 -1.60 -56.2% -28.9%
2026-04-03 -4.60 -2.70 -70.4% +11.5%
2025-11-13 -1.90 -1.30 -46.1% -2.4%
2025-08-12 -3.90 -1.10 -254.6% +5.6%
2024-11-05 -9.40 -5350.00 +99.8% -6.3%
2024-08-16 -1988.00 -6.00 -33033.3% +5.8%
2024-05-20 -400.00 -208.00 -92.3% -17.8%
2024-03-28 -1140.00 -600.00 -90.0% +75.4%
2023-11-13 -800.00 -1200.00 +33.3% +4.3%
2023-08-10 -400.00 -1600.00 +75.0% +0.0%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
SBFM ★ $0B — 0.0 0.1 1.3 0.0 33.0% -9.1% — -128.48%
LLY — 40.7 25.5 — 30.1 — 82.8% 55.5% 169.9% —
UNH $383B 31.7 19.0 0.9 17.7 3.9 19.5% 0.4% 61.5% 5.94%
JNJ $599B 28.8 19.4 6.1 18.4 7.4 68.1% 6.6% -1.0% —
MRK — 35.1 12.9 — 12.1 6.7 76.7% 4.9% — —
ABBV $448B 124.2 15.6 7.1 17.2 -67.3 72.0% 12.4% -46.2% 4.65%
PFE — 18.9 8.7 — 7.6 — 74.8% 5.4% -10.1% —
TMO — 28.9 19.3 — 21.1 — 40.9% 6.2% 11.3% —

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 0.58%

HolderShares% out
Citadel Advisors Llc 4,625 0.22%
Two Sigma Securities, LLC 2,348 0.11%
Xtx Topco Ltd 2,146 0.10%
Morgan Stanley 1,463 0.07%
Commonwealth Equity Services, LLC 1,344 0.06%
SBI Securities Co., Ltd. 183 0.01%
UBS Group AG 110 0.01%
National Bank of Canada/FI/ 1 —
Farther Finance Advisors, Llc 1 —

Insider activity · 90d

No insider trades for SBFM in last 90d.

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$56.0
Mean
$56.0
High
$56.0
Analysts
1
Recommendation distribution · period 2026-07-01
2
4
1
Revision trend (2026-04-01 → 2026-07-01): net 6 → 6 0 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
8-K 2026-07-10 CURRENT REPORT view ·
8-K 2026-05-29 CURRENT REPORT view ·
8-K 2026-05-19 CURRENT REPORT view ·
10-Q 2026-05-13 FORM 10-Q FOR MAR 2026 view ·
S-1 2026-05-12 FORM S-1 view ·
4 2026-04-14 Insider transaction (Form 4) view ·
8-K 2026-04-09 CURRENT REPORT view ·
10-K 2026-04-03 FORM 10-K FOR DEC 2025 view ·
8-K 2026-03-09 FORM 8-K view ·
8-K 2026-02-20 CURRENT REPORT view ·
8-K 2026-02-05 CURRENT REPORT view ·
8-K 2025-12-12 FORM 8-K view ·
10-Q 2025-11-13 FORM 10-Q FOR SEP 2025 view ·
DEF 14A 2025-10-23 DEFINITIVE PROXY view ·
8-K 2025-09-30 CURRENT REPORT view ·
10-Q 2025-08-12 FORM 10-Q FOR JUN 2025 view ·
S-1 2025-08-05 FORM S-1 view ·
8-K 2025-05-19 CURRENT REPORT view ·
10-Q 2025-05-15 FORM 10-Q FOR MAR 2025 view ·
8-K 2025-04-03 CURRENT REPORT view ·
8-K 2025-04-02 CURRENT REPORT view ·
10-K 2025-04-01 FORM 10-K FOR DEC 2024 view ·
8-K 2025-01-15 CURRENT REPORT view ·
8-K 2024-12-10 CURRENT REPORT view ·
8-K 2024-11-07 FORM 8-K view ·
10-Q 2024-11-05 FORM 10-Q FOR SEPT 2024 view ·
8-K 2024-10-23 CURRENT REPORT view ·
DEF 14A 2024-10-17 DEFINITIVE PROXY STATEMENT view ·
8-K 2024-09-10 FORM 8-K view ·
8-K 2024-08-19 FORM 8-K view ·
10-Q 2024-08-16 FORM 10-Q view ·
8-K 2024-08-12 FORM 8-K view ·
8-K 2024-07-02 FORM 8-K view ·
8-K 2024-07-01 FORM 8-K view ·
8-K 2024-06-11 CURRENT REPORT view ·
8-K 2024-06-07 FORM 8-K view ·
8-K 2024-05-22 FORM 8-K view ·
10-Q 2024-05-20 FORM 10-Q FOR MARCH 2024 view ·
8-K 2024-05-08 FORM 8-K view ·
8-K 2024-05-06 FORM 8-K view ·
8-K 2024-04-23 FORM 8-K view ·
8-K 2024-04-01 CURRENT REPORT view ·
10-K 2024-03-28 FORM 10-K FOR FYE END DEC 2023 view ·
8-K 2024-03-06 FORM 8-K view ·
4 2024-03-05 Insider transaction (Form 4) view ·
8-K 2024-03-01 FORM 8-K view ·
8-K 2024-02-16 FORM 8-K view ·
8-K 2024-02-15 CURRENT REPORT view ·
4 2024-02-12 Insider transaction (Form 4) view ·
8-K 2024-02-12 FORM 8-K view ·
S-1 2024-02-01 REGISTRATION STATEMENT view ·
8-K 2024-01-30 CURRENT REPORT view ·
8-K 2023-12-07 FORM 8-K view ·
8-K 2023-11-13 FORM 8-K view ·
10-Q 2023-11-13 FORM10-Q FOR SEPT 2023 view ·
8-K 2023-11-02 FORM 8-K view ·
8-K 2023-10-20 CURRENT REPORT view ·
DEF 14A 2023-10-18 DEFINITIVE PROXY STATEMENT view ·
8-K 2023-10-13 FORM 8-K view ·
8-K 2023-09-22 CURRENT REPORT view ·

About SBFM

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Options picks · SBFM

ITM + OTM ideas from the latest scan

Loading…

Congress trades · SBFM

STOCK Act disclosures

Loading…

SEC filings & insiders · SBFM

EDGAR · live

Loading…

Holders · SBFM

Institutions & insider activity

Loading…